Gail D Pearson

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders
    Gail D Pearson
    National Heart, Lung, and Blood Institute, National Institutes of Health, Division of Cardiovascular Diseases, Bethesda, MD 20892, USA
    Circulation 118:785-91. 2008
  2. ncbi Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy
    James M Roberts
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    Hypertens Pregnancy 22:109-27. 2003
  3. ncbi Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
    Ronald V Lacro
    Children s Hospital Boston and Harvard Medical School, Boston, MA 02115, USA
    Am Heart J 154:624-31. 2007

Collaborators

  • Lars Svensson
  • Lynn Sakai
  • FRANCESCO B RAMIREZ
  • J M Roberts
  • Ronald V Lacro
  • Jennifer S Li
  • Reed E Pyeritz
  • Lisa M Wruck
  • Stephen M Paridon
  • Beth F Printz
  • Timothy J Bradley
  • L Luann Minich
  • Lynn Mahony
  • Steven D Colan
  • J Philip Saul
  • Harry C Dietz
  • Richard B Devereux
  • Mary J Roman
  • Gloria L Klein
  • Elizabeth Radojewski
  • Mario P Stylianou

Detail Information

Publications3

  1. ncbi Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders
    Gail D Pearson
    National Heart, Lung, and Blood Institute, National Institutes of Health, Division of Cardiovascular Diseases, Bethesda, MD 20892, USA
    Circulation 118:785-91. 2008
  2. ncbi Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy
    James M Roberts
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    Hypertens Pregnancy 22:109-27. 2003
    ..Recommendations to increase participation in this research are also presented...
  3. ncbi Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
    Ronald V Lacro
    Children s Hospital Boston and Harvard Medical School, Boston, MA 02115, USA
    Am Heart J 154:624-31. 2007
    ..Recent studies in an FBN1-targeted mouse model of MFS with aortic disease similar to that seen in humans showed that treatment with losartan normalized aortic root growth and aortic wall architecture...